Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technical analysis for shorts & longs -- Ignore unavailable to you. Want to Upgrade?

To: Johnny Canuck who wrote (53283)	10/25/2020 4:44:34 AM
From: Johnny Canuck	Read Replies (1) \| Respond to of 69227

5.7 percent yield on ABBV: seekingalpha.com Johnny: A little less sure about the comments about the pipeline. They have 2 patents on drugs expiring next year (?) that represent a large percentage of their revenues. An analyst had a price target of $60 just a few months ago which tanked the stock. Tough part about drugs companies is it is hard to evaluate the drug pipeline. It is not the same company as when ABT was part of their revenue so not really a dividend aristocrat according to the strict definition.